A new study from Richard B. van Breemen at Oregon State University Department of Pharmaceutical Sciences, and co-authors from the Oregon Health & Science University Department of Microbiology & Immunology has been published in the American Chemical Society Journal of Natural Products, and shows that some cannabinoids found in hemp-- the male cannabis plant-- can help block the SARS-CoV-2 virus from binding to the ACE2 receptor and infecting a host. The specific cannabinoids-- CBDA and CBGA-- found in many of our full-spectrum CBD products, was found to increase apelin uptake and bind to the spike protein of the SARS-CoV-2 virus, blocking cellular entry of the virus into the host. From the study abstract: As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection−mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid...